RPGLF (Regent Pacific Group) OCF Margin %: -1,696.03% (As of Dec. 2025)


RPGLF Regent Pacific Group Ltd RPGLF
7 GF Score
Price $0.01
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group OCF Margin %?

Regent Pacific Group RPGLF 7 OCF Margin % is -1,696.03% as of Dec. 2025. GuruFocus rates RPGLF with a GF Score™ of 7/100. The stock has 7 warning signs investors should review. Among 959 Drug Manufacturers companies, Regent Pacific Group ranks worse than 96.87% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Regent Pacific Group's Cash Flow from Operations for the six months ended in Dec. 2025 was $-2.14 Mil. Regent Pacific Group's Revenue for the six months ended in Dec. 2025 was $0.13 Mil. Therefore, Regent Pacific Group's OCF Margin % for the quarter that ended in Dec. 2025 was -1,696.03%.

As of today, Regent Pacific Group's current OCF Yield % is -11.75%.

The historical rank and industry rank for Regent Pacific Group's OCF Margin % or its related term are showing as below:

RPGLF' s OCF Margin % Range Over the Past 10 Years
Min: -6063.12   Med: -503.83   Max: 443.58
Current: -1184.02

During the past 13 years, the highest OCF Margin % of Regent Pacific Group was 443.58%. The lowest was -6063.12%. And the median was -503.83%.

RPGLF's OCF Margin % is ranked worse than
96.87% of 959 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs RPGLF: -1184.02

Regent Pacific Group OCF Margin % Related Terms

Regent Pacific Group OCF Margin % Historical Data

* Premium members only.

The historical data trend for Regent Pacific Group's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regent Pacific Group OCF Margin % Chart

Regent Pacific Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.34 443.86 -1,308.59 -574.27 -1,184.02

Regent Pacific Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,221.19 -2,077.24 -264.09 -911.81 -1,696.03

RPGLF vs ZTS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regent Pacific Group OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's OCF Margin % falls into.


RPGLF
7GF Score
Regent Pacific Group Ltd RPGLF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regent Pacific Group OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Regent Pacific Group's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.298/0.363
=-1,184.02 %

Regent Pacific Group's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.137/0.126
=-1,696.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1,696.03% mean?
Regent Pacific Group (RPGLF) has a OCF Margin % of -1,696.03% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Regent Pacific Group and its competitors. According to the industry distribution chart, Regent Pacific Group ranks #929 out of 959 companies in the Drug Manufacturers industry, placing it in the top 96.9%.
Is Regent Pacific Group's OCF Margin % too high?
Regent Pacific Group's current OCF Margin % is -1,696.03%. Based on the distribution chart, Regent Pacific Group ranks #929 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Regent Pacific Group has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Regent Pacific Group ranks #929 out of 959 companies for OCF Margin %. This places Regent Pacific Group in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Regent Pacific Group and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regent Pacific Group's current OCF Margin % is -1,696.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Regent Pacific Group (RPGLF) has a current OCF Margin % of -1,696.03%. The current OCF Margin % is -1,696.03%. Regent Pacific Group's overall GF Score™ is 7/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Regent Pacific Group (RPGLF), the current OCF Margin % is -1,696.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regent Pacific Group Business Description

Other Exchanges 00575:Hong KongRPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
7GF Score

Get the complete analysis for RPGLF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price